Investor
Farrow Financial, Inc.
CIK 0002010644 · filed 2026-05-01 · SEC filing
13F book
$176.1M
Positions
53
1 new · 1 sold
Largest name
7.5%
Ishares Tr
Est. mark
−$1.97M
Price effect on 52 names still held. Flow $4.01M.
| Name | Ticker | Shares | Value | Weight | Est. mark | Change |
|---|---|---|---|---|---|---|
| Ishares Tr | — | 92.3K | $13.1M | 7.5% | −$577.8K | Cut−$754.9K |
| Ishares Tr | — | 97.5K | $12.9M | 7.3% | −$706.6K | Cut−$773.5K |
| Ishares Tr | — | 281.3K | $11.2M | 6.3% | $458.5K | Cut$437.6K |
| Vaneck Etf Trust | — | 104.6K | $10.1M | 5.7% | −$717.6K | Cut−$779.1K |
| Ishares 0-3 Month | — | 80.4K | $8.09M | 4.6% | $22.5K | Cut−$774.9K |
| Ishares Tr | — | 149.3K | $7.56M | 4.3% | $5.97K | Cut−$33.9K |
| Apple Inc. | AAPL | 26.8K | $6.79M | 3.9% | −$483.6K | Cut−$977.6K |
| Schwab Strategic Tr | — | 230.2K | $5.59M | 3.2% | −$23K | Cut−$52.4K |
| Ishares Tr | — | 39.3K | $5.34M | 3.0% | $555.2K | Cut$516.6K |
| Amplify Etf Tr | — | 114.3K | $5.13M | 2.9% | $39.5K | Added$100.1K |
| Nvidia Corp | NVDA | 26.4K | $4.6M | 2.6% | −$318.9K | Cut−$394.5K |
| Ishares Tr | — | 148.5K | $4.5M | 2.6% | — | New |
| Mastec Inc | MTZ | 13K | $4.19M | 2.4% | $1.36M | Cut$1.03M |
| Schwab Strategic Tr | — | 162.5K | $4.05M | 2.3% | −$23.9K | Added$515.3K |
| Schwab Strategic Tr | — | 124.3K | $3.94M | 2.2% | $148.7K | Added$1.53M |
| Alphabet Inc | — | 13.1K | $3.77M | 2.1% | −$328.5K | Added−$276.4K |
| Canadian Nat Res Ltd | — | 69.2K | $3.37M | 1.9% | $1.02M | Added$1.04M |
| Nrg Energy, Inc. | NRG | 21.4K | $3.12M | 1.8% | −$279.7K | Cut−$322.7K |
| Microsoft Corp | MSFT | 8.37K | $3.1M | 1.8% | −$920.2K | Added−$825.5K |
| Cisco Sys Inc | — | 39.6K | $3.08M | 1.7% | $22.2K | Cut−$7.08K |
| Plexus Corp | PLXS | 13.8K | $2.8M | 1.6% | $769.1K | Cut$274.2K |
| Consolidated Water Co. Ltd. | CWCO | 84.6K | $2.8M | 1.6% | −$183.5K | Cut−$460.3K |
| Nextera Energy Inc | — | 29.4K | $2.73M | 1.6% | $369.8K | Added$377K |
| Invesco Qqq Tr | — | 4.68K | $2.7M | 1.5% | −$173.4K | Added−$169.3K |
| Schwab Strategic Tr | — | 106.4K | $2.67M | 1.5% | −$94.1K | Added$485.8K |
| Quest Diagnostics Inc | DGX | 13.3K | $2.61M | 1.5% | $298.8K | Cut$236.7K |
| Costco Whsl Corp New | — | 2.56K | $2.55M | 1.4% | $249.7K | Added$942.2K |
| Canadian Natl Ry Co | — | 24.8K | $2.54M | 1.4% | $88.8K | Added$304.8K |
| Badger Meter Inc | BMI | 16.5K | $2.52M | 1.4% | −$356.3K | Added−$298.4K |
| Trimble Inc. | TRMB | 38.5K | $2.51M | 1.4% | −$493.7K | Added−$438K |
| Lincoln Elec Hldgs Inc | — | 9.64K | $2.4M | 1.4% | $91K | Cut−$254.3K |
| Jpmorgan Chase & Co. | — | 8.14K | $2.4M | 1.4% | −$228.5K | Cut−$923.8K |
| First Tr Exchange-Traded Fd | — | 23.1K | $2.38M | 1.4% | −$125.1K | Added−$87.8K |
| Eli Lilly & Co | LLY | 2.5K | $2.3M | 1.3% | −$387.9K | Cut−$485.7K |
| Vulcan Matls Co | — | 8.38K | $2.28M | 1.3% | −$108.2K | Cut−$149K |
| Global X Fds | — | 86.1K | $2.16M | 1.2% | −$404.7K | Added−$142.6K |
| BlackRock, Inc. | BLK | 2.2K | $2.12M | 1.2% | −$239K | Cut−$346K |
| Vanguard Index Fds | — | 3.06K | $1.83M | 1.0% | −$90.6K | Cut−$112.6K |
| Berkshire Hathaway Inc Del | — | 2 | $1.44M | 0.8% | −$73.3K | Held |
| Procter And Gamble Co | PG | 5.99K | $865.1K | 0.5% | $6.77K | Held |
| Spdr Series Trust | — | 15.4K | $814.2K | 0.5% | −$48.5K | Held |
| Crispr Therapeutics Ag | CRSP | 17K | $807.7K | 0.5% | −$78.6K | Added−$38.2K |
| Illinois Tool Wks Inc | — | 2.93K | $763.4K | 0.4% | $41K | Cut$37.3K |
| Ishares Tr | — | 7.42K | $736.2K | 0.4% | −$4.42K | Added$12.3K |
| Spdr S&P 500 Etf Tr | — | 792 | $515.1K | 0.3% | −$25K | Held |
| Berkshire Hathaway Inc Del | — | 983 | $471.1K | 0.3% | −$23.1K | Cut−$43.2K |
| Ishares Tr | — | 4.12K | $372.6K | 0.2% | $4.4K | Cut−$1.95K |
| Spdr Series Trust | — | 4.03K | $368.9K | 0.2% | $1.05K | Cut−$11.6K |
| Global X Fds | — | 8.38K | $348.2K | 0.2% | −$15.6K | Added−$13.8K |
| Johnson & Johnson | JNJ | 1.12K | $273.8K | 0.2% | $42K | Held |
| Regions Financial Corp New | — | 10K | $261.2K | 0.1% | −$9.8K | Cut−$23.4K |
| Amazon Com Inc | AMZN | 1.06K | $220.3K | 0.1% | −$23.9K | Held |
| Lineage Cell Therapeutics In | — | 11.5K | $18.2K | 0.0% | −$1.03K | Held |
Positions as of Q1 2026. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.